Polaris Pharmaceuticals 2025 Q4 Financial Report
Polaris Pharmaceuticals, Inc. (stock code: 6550) reported a basic EPS of -5.10 NTD, revenue of 0.41 billion NTD, and a net loss after tax of 3.945 billion NTD for the fourth quarter of 2025.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:21 (16h 20m after Collected)
Company Code: 6550 Company Name: Polaris Pharmaceuticals, Inc. Industry: Biotechnology and Medical Care Fiscal Period: 2025 Q4 Basic Earnings Per Share (EPS): -5.10 NTD Operating Revenue: 0.41 billion NTD Net Income After Tax: -3.945 billion NTD